Winmill & Co’s HCA Healthcare HCA Stock Holding History

Winmill & Co’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,450	Closed	-$12.5M	–	59
2026 Q1	$12.5M	Hold	26,450	–	–	3.61%	13
2025 Q4	$12.3M	Hold	26,450	–	–	3.29%	15
2025 Q3	$11.3M	Buy	+26,450	New	+$10.3M	2.73%	18

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Winmill & Co's HCA Position: Q2 2026 in Review

Winmill & Co sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 26,450 shares — an estimated $12.5M sold.

Winmill & Co first reported a position in HCA in Q3 2025 and held it in 3 quarters. The position peaked at $12.5M in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Winmill & Co reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
Winmill & Co sold 26,450 HCA Healthcare shares in Q2 2026, an estimated $12.5M.
Winmill & Co first reported a position in HCA Healthcare in Q3 2025 and held it in 3 quarters.
Winmill & Co's HCA Healthcare position peaked at $12.5M in Q1 2026.
1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Winmill & Co's 13F filing for Q2 2026, filed 13 Aug 2026.